Abstract
As an initial step in testing the hypothesis that immunoregulatory abnormalities are important in the pathogenesis of primary sclerosing cholangitis, we determined the number and percentage of lymphocyte subsets in the peripheral blood of 33 patients with primary sclerosing cholangitis. In these patients, when compared with normal and diseased controls, there was a significant reduction in the total number of circulating T cells because of a disproportionate decrease in Leu-2a (suppressor/cytotoxic) cells. This decrease resulted in a significantly increased ratio of Leu-3a to Leu-2a cells. Patients with cirrhosis had significantly higher Leu-3a/Leu-2a (helper/suppressor) ratios than did noncirrhotic patients; both disease groups, however, had ratios that were significantly higher than controls. The number and percentage of B cells were significantly increased. Alterations in the percentage of B cells correlated significantly with histologic stage and concentrations of gamma globulin, serum IgG, and bilirubin. We conclude that these abnormalities are suggestive of a defect in immunoregulation in primary sclerosing cholangitis, which is not secondary to advanced liver disease alone and appears to be independent of chronic ulcerative colitis,or obstructive jaundice.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
LaRusso NF, Wiesner RH, Ludwig J, MacCarty RL: Primary sclerosing cholangitis. N Engl J Med 310:899–903, 1984
McFarlane IG, Wojcicka BM, Tsantoulas DC, Portmann BC, Eddleston ALWF, Williams R: Leukocyte migration inhibition in response to biliary antigens in primary biliary cirrhosis, sclerosing cholangitis, and other chronic liver diseases. Gastroenterology 76:1333–1340, 1979
Schrumpf E, Fausa O, Førre O, Dobloug JH, Ritland S, Thorsby E: HLA antigens and immunoregulatory T cells in ulcerative colitis associated with hepatobiliary disease. Scand J Gastroenterol 17:187–191, 1982
Chapman RW, Varghese Z, Gaul R, Patel G, Kokinon N, Sherlock S: Association of primary sclerosing cholangitis with HLA-B8. Gut 24:38–41, 1983
Wiesner RH, LaRusso NF, Ludwig J, Dickson ER: Comparison of the clinicopathologic features of primary sclerosing cholangitis and primary biliary cirrhosis. Gastroenterology 88:108–114, 1985
Bodenheimer HC Jr, LaRusso NF, Thayer WR Jr, Charland C, Staples PJ, Ludwig J: Elevated circulating immune complexes in primary sclerosing cholangitis. Hepatology 3:150–154, 1983
Minuk GY, Angus M, Brickman CM, Lawley TJ, Frank MM, Hoofnagle JH, Jones EA: Abnormal clearance of immune complexes from the circulation of patients with primary sclerosing cholangitis. Gastroenterology 88:166–170, 1985
Brinch L, Teisberg P, Schrumpf E, Akesson I: Thein vivo metabolism of C3 in hepatobiliary disease associated with ulcerative colitis. Scand J Gastroenterol 17:523–527, 1982
Whiteside TL, Lasky S, Si L, Van Thiel DH: Immunologic analysis of mononuclear cells in liver tissues and blood of patients with primary sclerosing cholangitis. Hepatology 5:468–474, 1985
Lennard-Jones JE, Ritchie JK, Hilder W, Spicer CC: Assessment of severity in colitis: A preliminary study. Gut 16:579–584, 1975
Ludwig J, Barham SS, LaRusso NF, Elveback LR, Wiesner RH, McCall JT: Morphologic features of chronic hepatitis associated with primary sclerosing cholangitis and chronic ulcerative colitis. Hepatology 1:632–640, 1981
Ledbetter JA, Evans RL, Lipinski M, Cunningham-Rundles C, Good RA, Herzenberg LA: Evolutionary conservation of surface molecules that distinguish T lymphocyte helper/inducer and cytotoxic/suppressor subpopulations in mouse and man. J Exp Med 153:310–323, 1981
Miller KB, Elta GH, Rudders RA, Kaplan MM: Lymphocyte subsets in primary biliary cirrhosis. Ann Intern Med 100:385–387, 1984
Morimoto C, Reinherz EL, Schlossman SF, Schur PH, Mills JA, Steinberg AD: Alterations in immunoregulatory T cell subsets in active systemic lupus erythematosus. J Clin Invest 66:1171–1174, 1980
Morimoto C, Reinherz EL, Distaso JA, Steinberg AD, Schlossman SF: Relationship between systemic lupus erythematosus T cell subsets, anti-T cell antibodies, and T cell functions. J Clin Invest 73:689–700, 1984
Alexander GJM, Nouri-Aria K-T, Eddleston ALWF, Williams R: Contrasting relations between suppressor-cell function and suppressor-cell number in chronic liver disease. Lancet 1:1291–1293, 1983
Schandené L, Vanden Steen F, Romasco F, Wybran J: Active T rosettes, human autologous T rosettes, OKT8 and OKT4 cells, con A-induced suppressive activity, and autoantibodies: Clinical correlations. Clin Immunol Immunopathol 28:147–154, 1983
Godin NJ, Sachar DB, Winchester R, Simon C, Janowitz HD: Loss of suppressor T-cells in active inflammatory bowel disease. Gut 25:743–747, 1984
Author information
Authors and Affiliations
Additional information
This work was supported by the Mayo Foundation and Sandoz Inc., East Hanover, New Jersey.
Rights and permissions
About this article
Cite this article
Lindor, K.D., Wiesner, R.H., Katzmann, J.A. et al. Lymphocyte subsets in primary sclerosing cholangitis. Digest Dis Sci 32, 720–725 (1987). https://doi.org/10.1007/BF01296138
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01296138